Ex-McKinsey Partner Jailed for Obstructing Purdue Pharma Opioid Probe

---

Full Story

A former McKinsey & Co partner received a six-month prison sentence for obstructing justice in a Purdue Pharma investigation. The partner destroyed records related to advice on boosting OxyContin sales. The case highlights accountability in the opioid crisis. McKinsey’s role in the crisis has drawn significant scrutiny.

The former partner was sentenced on Thursday for their actions. They deleted records tied to McKinsey’s work with Purdue Pharma.

MEDIA REPORTING

See how news sources on all sides are covering this story.

Left 35% | Right 27% | Center 31% | Unrated 8%

The Context

Purdue Pharma’s OxyContin is a prescription painkiller linked to the opioid epidemic. The drug’s aggressive marketing fueled widespread addiction in the U.S.

McKinsey advised Purdue on strategies to “turbocharge” OxyContin sales. The consulting firm’s role has led to legal and public backlash.

The opioid crisis has caused hundreds of thousands of deaths in the U.S. It remains a major public health challenge nationwide.

Obstruction of justice charges reflect efforts to hold corporate actors accountable. Destroying evidence can impede investigations into corporate misconduct.

Some believe harsh penalties deter corporate wrongdoing in public health crises. Others argue individual sentences don’t address systemic issues in consulting.

The U.S. legal system increasingly targets corporate involvement in the opioid epidemic. Settlements and convictions aim to provide justice for affected communities.